Healthcare
Sweden is a global leader in life sciences and precision medicine, investing over 3% of its GDP in R&D and fostering collaboration among top-tier universities, healthcare providers, and private companies. The country's healthcare system is renowned for its innovation and efficiency, supported by strong policies and continuous technological investment. Swedish advancements, such as the pacemaker and CRISPR-Cas9 gene editing, highlight its impact on global health, with major companies like Elekta and AstraZeneca mentoring numerous startups in the sector.
One of the most
advanced healthcare systems in the world
10% of Sweden’s
export lies in the Life Science sector
One of the highest
rates of patent filings
in the life sciences
sector in Europe
The Karolinska Institute
in Stockholm is responsible for selecting the Nobel laureates in
Physiology or Medicine​
Overview
Life science has the power to unlock the major health and societal challenges and opportunities of today, and tomorrow. Data-driven healthcare combined with scientific breakthroughs are revolutionising treatment opportunities – paving the way for improved preventive approaches and addressing complex medical and individual needs through precision medicine.
Sweden's healthcare system is internationally renowned for its model of innovation and efficiency, driven by strong policy support, a commitment to universal health coverage, and an ongoing investment in technology and preventive care. These features contribute to its reputation as one of the most advanced healthcare systems in the world with cutting-edge research in the fields of biotechnology, pharmaceuticals, medical technology, life sciences, precision medicine and healthcare. This is mainly because Sweden has several top-tier universities and research institutions.
​
The presence of world-renowned universities and research institutions, such as the Karolinska Institutet, which awards the Nobel Prize in Physiology or Medicine, underscores Sweden's prominence in medical research. This ecosystem is complemented by a robust economy that supports innovation and development in various high-tech sectors, including precision medicine. Sweden’s approach is not just about funding; it's about creating a synergistic environment that includes government support, corporate involvement, and academic freedom, making it a prime destination for research and development in life sciences and precision medicine.
​
Sweden has established itself as a global leader in life sciences and precision medicine, driven by its commitment to research and development (R&D). The country invests over 3% of its GDP in R&D, a significant portion of which is directed towards life sciences. This investment fosters an environment where academic institutions, healthcare providers, and private companies collaborate closely, contributing to advancements in medical research and healthcare technologies.
​
Sweden is considered one of the world's most prominent research nations and has historically been a country of life science innovations. 10% of Sweden’s exports lie in the Life Science sector. Swedish innovations such as the pacemaker, stereotactic radiosurgery and omeprazole have made an impact on the health and quality of life of millions of people. As the world switches to a new way of thinking and living, the life science sector has the potential and opportunity to accelerate research and innovation that will meet immediate and long-term healthcare needs, with a focus on data-driven solutions in preventative and precision medicine, infection control, and disease management.
​
Emmanuelle Charpentier's research at Umeå University has laid the foundation for one of today's greatest achievements in molecular biology and cell biology research, for which she received the 2020 Nobel Prize in Chemistry. All over the world, the CRISPR-Cas9 gene editing tool is now used by thousands of scientists in biology and medicine to alter the DNA of cells with high precision. Sweden also has a significant presence of multinational pharmaceutical and biotech companies, such as Elekta and AstraZeneca, that act as mentors to some of the numerous innovative startups and SMEs.
Photo: Naina Helén Jåma/imagebank.sweden.se
Research
Sweden's life science ecosystem is anchored by world-renowned universities and research institutions, such as Karolinska Institutet, Uppsala University, and Lund University, fostering groundbreaking research and innovation in biomedical sciences. The country's strong emphasis on science and technology in healthcare is evident from its consistent production of innovative medical research and technologies. This is supported by institutions and universities and various biotechnology and pharmaceutical companies based in Sweden.
​
The following are some of the notable features of the Swedish healthcare system:
Digital Health Services: Sweden is a leader in the utilisation of digital healthcare technology. This includes comprehensive electronic health records (EHR) systems, which are among the best developed in the world. The country was also the first to adopt nationwide EHR, contributing to its high ranking in healthcare innovation.
​
Learn more:​
OPP - Sweden: #15 in the 2020 World Index of Healthcare Innovation
Swecare - Healthcare in Sweden
Patient-Centered Care and Preventive Services: Swedish healthcare also emphasises preventive care and patient-centered services. There are national programs aimed at promoting healthy lifestyles and regular screening. The system also ensures that children and adolescents up to a certain age receive free healthcare services, which underlines its preventive and inclusive approach.
​
Learn more:
Swedish Healthcare - Overview of the Health System (healthmanagement.org)​.
Innovative Care Models: The Esther Model is one such innovation, developed to improve care coordination for elderly patients with complex conditions. This model is just one example of how Sweden looks to innovate in patient care by focusing on specific needs and efficient care processes.
​
Learn more:
Global Collaborations and Health System Reforms: Sweden is involved in international partnerships, such as the WHO Primary Health Care (PHC) Demonstration Platforms, which aim to enhance PHC transformation globally. Domestically, Sweden has seen various health system reforms aimed at improving service availability, patient choice, and system efficiency.
​
Learn more:
World Health Organization - an innovative approach to enhancing PHC transformation
​European Health Observatory - Sweden: health system review 2023
Robust Industry Clusters
Sweden has a state-of-the-art infrastructure for life science research and development, including specialised laboratories, incubators, and technology parks. We host several life science clusters, including Medicon Village in Lund, Stockholm-Uppsala Life Science, and BioVentureHub in Gothenburg, which facilitate collaboration between academia, industry, and healthcare providers, promoting the commercialisation of research. The availability of skilled researchers, engineers, and healthcare professionals is a great contribution to the ecosystem's success. Swedish Life Science companies are known for their focus on innovation, particularly in areas such as precision medicine, genomics, and digital health. Emerging technologies like AI and CRISPR/Cas9 are increasingly being integrated into research and development efforts. This research is conducted with sustainability and ethical considerations as keywords.
Collaborative Ecosystem Triple Helix
Sweden's life science ecosystem is characterised by a high degree of collaboration between various stakeholders, including universities, hospitals, startups, and established companies, leading to a vibrant environment for innovation and development in areas such as biotechnology, pharmaceuticals, and medical technology. This Triple Helix model is a key that together with the public-private partnerships, research consortia, and joint initiatives all foster innovation and knowledge exchange.
​Government Support and Investment
The Swedish government provides substantial support for the life science sector through funding agencies like Vinnova and initiatives such as the National Life Science Strategy, aiming to position Sweden as a global leader in health and life sciences. In addition, the Swedish healthcare system is decentralised, giving significant responsibilities to regional and local governments. This system ensures universal health coverage for all residents, which contributes to high public funding and low levels of unmet health needs. The Swedish government provides substantial support for life science research and innovation through funding programs, tax incentives, and favourable regulatory policies. Agencies like Vinnova play a key role in promoting R&D activities.
Learn about pioneering Swedish
innovations within life sciences and more
Learn More:
A Selection of Government Bodies
Business Sweden - Life Science
Region Skåne Innovation (Healthcare)
Swedish Ministry of Health and Social Affairs (Socialdepartementet)
Sweden's National Life Science Strategy
The National Board of Health and Welfare (Socialstyrelsen)
The Public Health Agency of Sweden (Folkhälsomyndigheten
The Swedish eHealth Agency (E-hälsomyndigheten)
Karolinska University Hospital​
Sahlgrenska University Hospital​
​
A Selection of Private Entities
